NDC00003-0265-20: IODIPAMIDE MEGLUMINE INJECTION.
The IODIPAMIDE MEGLUMINE INJECTION is a the manufacturer industrial component. Key specifications include special_features: ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT, primary_container_type: VIAL, supplementary_features: D-DAY ITEM FOR DOD, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, pharmaceutical_vehicle_type: AQUEOUS, medical_designation_and_grade: UNITED STATES PHARMACOPEIA. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-926-9109, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT |
| primary_container_type | VIAL |
| supplementary_features | D-DAY ITEM FOR DOD |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| pharmaceutical_vehicle_type | AQUEOUS |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 20.000 MILLILITERS |
| part_name_assigned_by_controlling_agency | IODIPAMIDE MEGLUMINE INJECTION USP 52% 20ML |
| NSN | 6505-00-926-9109 |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.000 MILLILITERS |
| SUPPLEMENTARY FEATURES | D-DAY ITEM FOR DOD |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL |
| SPECIAL FEATURES | ACTIVE MEDICAMENT MEDICINAL STRENGTH: 52.000 PERCENTAGE, W/V MEGLUMINE IODIPAMIDE ACTIVE INGREDIENT |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | IODIPAMIDE MEGLUMINE INJECTION USP 52% 20ML |
| PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
No substitute or cross-reference records for this part.